- Company Overview for YORKDALE PHARMA LIMITED (13473836)
- Filing history for YORKDALE PHARMA LIMITED (13473836)
- People for YORKDALE PHARMA LIMITED (13473836)
- More for YORKDALE PHARMA LIMITED (13473836)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
09 Apr 2024 | CS01 | Confirmation statement made on 30 March 2024 with no updates | |
23 Mar 2024 | AA | Full accounts made up to 30 June 2023 | |
05 Mar 2024 | PSC07 | Cessation of Cortex 3 Guernsey Limited as a person with significant control on 22 November 2021 | |
23 Feb 2024 | RP04PSC01 | Second filing for the notification of Guy Semmens as a person with significant control | |
18 Jul 2023 | AP01 | Appointment of Mrs Emma Jane Johnson as a director on 1 July 2023 | |
18 Jul 2023 | TM01 | Termination of appointment of Steen Vangsgaard as a director on 30 June 2023 | |
30 Mar 2023 | CS01 | Confirmation statement made on 30 March 2023 with updates | |
24 Feb 2023 | AA | Full accounts made up to 30 June 2022 | |
19 Jul 2022 | CS01 | Confirmation statement made on 22 June 2022 with no updates | |
18 Jul 2022 | RP04AP01 | Second filing for the appointment of Mr Andrew Michael Webb as a director | |
10 May 2022 | AP01 |
Appointment of Mr Andrew Michael Webb as a director on 1 May 2022
|
|
10 May 2022 | TM01 | Termination of appointment of Ingvild Liborg as a director on 30 April 2022 | |
25 Nov 2021 | AD01 | Registered office address changed from Rosemont House Yorkdale Industrial Park Braithwaite Street Leeds LS11 9XE England to 8a Crabtree Road Egham Surrey TW20 8RN on 25 November 2021 | |
25 Nov 2021 | TM01 | Termination of appointment of Howard Langton Taylor as a director on 22 November 2021 | |
25 Nov 2021 | TM01 | Termination of appointment of Iain Fawcett as a director on 22 November 2021 | |
25 Nov 2021 | TM01 | Termination of appointment of Timothy Mark Busby as a director on 22 November 2021 | |
25 Nov 2021 | AP01 | Appointment of Ingvild Liborg as a director on 22 November 2021 | |
25 Nov 2021 | AP01 | Appointment of Benjamin Matthew Ash as a director on 22 November 2021 | |
25 Nov 2021 | AP01 | Appointment of Steen Vangsgaard as a director on 22 November 2021 | |
25 Nov 2021 | PSC07 | Cessation of Rosemont Pharmaceuticals Limited as a person with significant control on 22 November 2021 | |
25 Nov 2021 | PSC02 | Notification of Cortex 3 Guernsey Limited as a person with significant control on 22 November 2021 | |
25 Nov 2021 | PSC01 |
Notification of Guy Semmens as a person with significant control on 22 November 2021
|
|
02 Jul 2021 | CH01 | Director's details changed for Mr Howard Langton Taylor on 23 June 2021 | |
23 Jun 2021 | NEWINC |
Incorporation
Statement of capital on 2021-06-23
|